ELEVANCE HEALTH INC (ELV)

US0367521038 - Common Stock

518.54  -1.42 (-0.27%)

After market: 518.54 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
138.639B
13.76%
156.595B
12.95%
171.34B
9.42%
173.889B
1.49%
N/AN/AN/A
EBITDA
YoY % growth
10.457B
17.96%
10.126B
-3.17%
11.242B
11.02%
12.62B
12.26%
EBIT
YoY % growth
9.155B
18.73%
8.451B
-7.69%
9.497B
12.38%
11.572B
21.85%
N/AN/AN/AN/A
Operating Margin
6.60%5.40%5.54%6.65%N/AN/AN/AN/A
EPS
YoY % growth
25.97
15.83%
29.05
11.86%
33.11
13.98%
37.52
13.32%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
10.55
11.56%
Revenue
Q2Q % growth
42.966B
1.88%
EBITDA
Q2Q % growth
3.402BN/AN/AN/AN/A
EBIT
Q2Q % growth
3.334B
16.17%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
5.62
7.46%
5.70-0.08-1.40%
Q3 2023
Q2Q % growth
8.99
19.39%
8.520.475.47%
Q2 2023
Q2Q % growth
9.04
12.44%
8.880.161.75%
Q1 2023
Q2Q % growth
9.46
14.67%
9.350.111.13%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
42.647B
6.81%
42.466B181M0.43%
Q3 2023
Q2Q % growth
42.849B
7.29%
43.042B-193M-0.45%
Q2 2023
Q2Q % growth
43.672B
13.05%
41.917B1.755B4.19%
Q1 2023
Q2Q % growth
42.172B
10.70%
41.24B932M2.26%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.31% 0.06% 0.26% 0.17%
Revenue0.41% -1.12% 0.19% -1.18%